FRIDAY, NOVEMBER 24, 2017

Researchers: Telomeres may be key to fighting diseases

Researchers have discovered that rearranging pieces of DNA called telomeres help diseases like herpes flourish and may be key to fighting such illnesses in the future. Read More »

FDA approves adult Fluzone Intradermal Quadrivalent flu vaccine

The U.S. Food and Drug Administration (FDA) approved Sanofi Pasteur's application for a Fluzone Intradermal Quadrivalent vaccine supplemental biologics license on Friday. Read More »

Researchers identify gene resistant to malaria treatment

Scientists recently discovered that the Plasmodium falciparum parasite (the parasite responsible for malaria) contains the single mutated gene (K13) responsible for increasing resistance to malaria treatments in Southeast Asia. Read More »

England a step closer to meningitis vaccine access

The Meningitis Research Foundation sent out its own version of Christmas cheer recently in the form of some positive news: A mandate is in place to implement a MenB vaccine in England once price negotiations conclude. Read More »

Study: Compound shows promise against malaria

A new study, performed at St. Jude Children's Research Hospital, with results recently published in Proceedings of the National Academy of Sciences, shows promise in defeating malaria. Read More »

Researchers create potential HIV vaccine candidate

A team of Seattle researchers led by Dr. Leo Stamatatos recently created an HIV vaccine candidate that could induce the immune system to defend against a wide range of HIV strains. Read More »

Arrowhead submits FDA application for hep B treatment

Arrowhead Research Corporation, a biopharmaceutical company specializing in creating targeted RNAi therapies, recently submitted an application to the U.S. Food and Drug Administration (FDA) for further testing of a new drug, called ARC-520, to treat chronic hepatitis B virus infection. Read More »

Study: Mouth bacteria may help with oral vaccine delivery

Scientists and researchers at the Forsyth Institute and Tufts University recently discovered that Streptococcus mitis, a common mouth bacteria, may help with oral vaccinations. Read More »

Flublok vaccine touted as solution to new flu virus threat

There might be a solution in the wake of the Centers for Disease Control and Prevention's recent warning that the current influenza vaccine may not work this season after a new strain of the flu virus began circulating. Read More »

Pharmaceutical companies collaborate on new Ebola drug

CMC Biologics and OncoSynergy agreed on Tuesday to collaborate on the development and manufacturing of OS2966 as a potential Ebola treatment. Read More »

First West Nile Virus case confirmed in Brazil

The Ministry of Health of Brazil confirmed the first human case of West Nile Virus in the country on Dec. 9. Read More »

Chinese study shows entecavir preventing hepatitus B in chemotherapy patients

In a recent study conducted at Sun Yat-sen University Cancer Center in China, researchers found that lymphoma patients undergoing chemotherapy getting the drug entecavir had a smaller incidence of acquiring hepatitis B. Read More »

Walgreens Flu Index has latest statistics on flu activity in U.S.

The Walgreens Flu Index for the week ending Dec. 12, 2014, shows the latest statistics for designated market areas where cases of the flu are increasing and decreasing. Read More »

Valneva begins Phase II Clostridium difficile vaccine trial

Valneva SE, a biotechnology company based in Europe, recently started Phase II clinical trial of its VLA84-201 prophylactic vaccine treatment for Clostridium difficile, a bacteria that is notoriously difficult to treat. Read More »

Ablynx seeks infant, toddler RSV trial subjects

Ablynx, a biopharmaceutical company, recently announced that it is accepting infant- and toddler-aged subjects for a Phase IIa study of ALX-0171, an anti-Respiratory Syncytial Virus (RSV) Nanobody treatment. Read More »

Ukraine TB outbreak has potential to be full-blown epidemic

Ukraine is going through a tuberculosis outbreak and one organization believes it could have been avoided. Read More »

14 arrests made in NECC-connected meningitis outbreak from 2012

Federal law enforcement officials on Wednesday arrested 14 owners and employees of New England Compounding Center on several charges stemming from the deadly 2012 fungal meningitis outbreak. Read More »

FDA approves latest Gardasil HPV vaccine

The Food and Drug Administration recently approved Gardasil 9, which guards against nine strains of the human papillomavirus (HPV). Read More »

Study: Boosted flu vaccine benefits elderly in care facilities

A study published Thursday finds that the Fluzone High-Dose vaccine, which contains four times more antigens than the regular vaccine, benefits elderly recipients who live in long-term care facilities. Read More »

WHO: TB on the rise in several countries

The World Health Organization (WHO) recently reported in its “Global Tuberculosis (TB) Report 2014" that the rate of TB is on the rise around the world. Read More »